Differentiating Approach to Acne Therapy: Women vs. Men
Join Drs. Leon H. Kircik, MD and Julie Harper, MD as they discuss Acne severity and grade (comedonal, papulopustular, mixed, nodular), skin type, presence of acne scarring and postinflammatory hyperpigmentation, menstrual cycle history (in women), and more, as well as the factors influencing treatment with classes of topical agents.
Acne vulgaris is a chronic inflammatory dermatologic disease affecting an estimated 80% of the population at some point in their life; 85% of adolescents and young adult s may experience acne and prevalent in adults with more adult women being afflicted than adult men, raising the possibility that gender difference in skin may influence the pathogenesis of acne and treatment response.
Dermatologists indicate late-onset or adult -onset acne is becoming increasingly common in women in their 20s to 50s and research shows a large number of women over age 25 have acne and the prevalence of acne remains constant until age 44 at which time there is a decrease in incidence.
FACULTY
Leon H. Kircik, MD
Clinical Professor of Dermatology
Indiana University School of Medicine
Mount Sinai Medical Center, New York, NY
Physicians Skin Care, PLLC
Louisville, KY
Julie C. Harper, MD
Clinical Associate Professor of Dermatology
University of Alabama-Birmingham
Birmingham, Alabama
Watch Now
You May Also Like
Unlocking the Adherence Puzzle in Acne Management Have you read this latest insightful review from the Journal of Drugs in Dermatology (JDD)? Acne vulgaris remains one of the most frequent…
Targeting Fibroproliferative Disorders: Could JAK Inhibitors Lower Keloid and Hypertrophic Scar Risk? Here is an essential new report from the JDD that could shift how we think about scar prevention.…
Check Out JDD’s Latest Author Spotlight Our current Author Spotlight features Jessica L. Feig MD PhD, one of the co-authors of JAK/STAT Inhibitors Reduce Risk of New-Onset Keloids and Hypertrophic…
